Area of research
Pulmonary and Respiratory Medicine · Epidemiology
Research interest
Research interests include Chemistry, Macrophage, KEAP1, Pyroptosis, Medicine, and Internal medicine.
Plaque erosion risk and <i>JAK2</i> V617F variant
Targeting KEAP1/NRF2 interaction with oleuropein ameliorates atherosclerosis by inhibiting macrophage ferroptosis
Meta-analysis of the clinical efficacy and safety of single versus dual plate in the treatment of comminuted distal femur fractures
Corrigendum to “MCL attenuates atherosclerosis by suppressing macrophage ferroptosis via targeting KEAP1/NRF2 interaction” [Redox Biol. 69 (2024) 102987]
MCL attenuates atherosclerosis by suppressing macrophage ferroptosis via targeting KEAP1/NRF2 interaction
Homocysteine promotes atherosclerosis through macrophage pyroptosis via endoplasmic reticulum stress and calcium disorder
SARS-CoV-2 Nsp15 suppresses type I interferon production by inhibiting IRF3 phosphorylation and nuclear translocation
iATMEcell: identification of abnormal tumor microenvironment cells to predict the clinical outcomes in cancer based on cell–cell crosstalk network
A novel anti-atherosclerotic mechanism of quercetin: Competitive binding to KEAP1 via Arg483 to inhibit macrophage pyroptosis
Prevalence and prognostic significance of DNMT3A- and TET2- clonal haematopoiesis-driver mutations in patients presenting with ST-segment elevation myocardial infarction
Anti-atherosclerotic effects of geraniin through the gut microbiota-dependent trimethylamine N-oxide (TMAO) pathway in mice
Analysis of Tumor Microenvironment Heterogeneity among Breast Cancer Subtypes to Identify Subtype-Specific Signatures
A novel pathway mutation perturbation score predicts the clinical outcomes of immunotherapy
Tumor Microenvironment Characterization in Breast Cancer Identifies Prognostic Pathway Signatures
DrugSim2DR: systematic prediction of drug functional similarities in the context of specific disease for drug repurposing
Identification of comutation in signaling pathways to predict the clinical outcomes of immunotherapy
Corrigendum to “A novel anti-atherosclerotic mechanism of quercetin: Competitive binding to KEAP1 via Arg483 to inhibit macrophage pyroptosis” [Redox Biol. 57 (2022) 102511]
Luteolin prevents THP-1 macrophage pyroptosis by suppressing ROS production via Nrf2 activation
Polyphenols from blue honeysuckle (Lonicera caerulea var. edulis) berry inhibit lipid accumulation in adipocytes by suppressing lipogenesis
Polyphenols from Blue Honeysuckle (<em>Lonicera caerulea</em> L. var. <em>edulis</em>) Berry Inhibit Lipid Accumulation in Adipocytes by Suppressing Lipogenesis
Omentin-1 protects against high glucose-induced endothelial dysfunction via the AMPK/PPARδ signaling pathway
Hepatoprotective effect of 2′-O-galloylhyperin against oxidative stress-induced liver damage through induction of Nrf2/ARE-mediated antioxidant pathway
Inhibitory effects of geraniin on LPS-induced inflammation via regulating NF-κB and Nrf2 pathways in RAW 264.7 cells
Irgm1 promotes M1 but not M2 macrophage polarization in atherosclerosis pathogenesis and development